Literature DB >> 11315276

Bilateral high loop ureterostomy in the primary management of posterior urethral valves in a developing country.

P Parag1, S Sen, J Chacko, N Zachariah, G Thomas, K E Mammen.   

Abstract

Of 200 consecutive cases of posterior urethral valves (PUV) managed in a single institution, 26 underwent bilateral high loop ureterostomy (BU) as their first operative intervention. Indications for BU were persistently raised serum creatinine levels after bladder drainage, severe urosepsis, and urinary ascites, especially in a neonate or infant. After a median period of 1 year of diversion, the serum creatinine fell from a median value of 2.5 to 0.6 mg%. Twelve cases have been fully undiverted without deleterious effects (median serum creatinine level 0.5 mg%). Three patients died. Of the 14 renal units with documented persistent vesicoureteric reflux at the time of undiversion, only 1 has been reimplanted. One child has undergone bladder augmentation.

Entities:  

Mesh:

Year:  2001        PMID: 11315276     DOI: 10.1007/s003830000464

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  4 in total

1.  Bilateral ureterocutaneostomy with modified stoma: long-term follow-up.

Authors:  S V Chitale; V R Chitale
Journal:  World J Urol       Date:  2006-04-22       Impact factor: 4.226

2.  Posterior Urethral Valves in Children: Pattern of Presentation and Outcome of Initial Treatment in Ile-Ife, Nigeria.

Authors:  Ademola Olusegun Talabi; Oludayo Adedapo Sowande; Amarachukwu Chiduziem Etonyeaku; Abdulkadir A Salako; Olusanya Adejuyigbe
Journal:  Niger J Surg       Date:  2015 Jul-Dec

3.  Does Early Upper Tract Diversion and Delayed Undiversion in Megaureters Secondary to Severe Posterior Urethral Valves Lead to Better Renal Outcomes?

Authors:  Somnath Prathap; Sarath Kumar Narayanan
Journal:  J Indian Assoc Pediatr Surg       Date:  2022-03-01

4.  Posterior Urethral Valves; A single Center Experience.

Authors:  Alireza Mirshemirani; Ahmad Khaleghnejad; Mohsen Rouzrokh; Afsaneh Sadeghi; Leila Mohajerzadeh; Mustafa Sharifian
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.